Pharmafile Logo
Pharmafocus logo
Advanced Search

Research and Development

Showing 15 posts of 9594 posts found.

Celgene

January 1, 2010 Research and Development, Sales and Marketing Abraxane, Celgene, Revlimid, Thalidomide

Founded in 1986, Celgene was created as a spin off from the Celanese Corporation. Two years later, the company received …
Feature

Pharma mergers and acquisitions in 2009

December 22, 2009 Research and Development, Sales and Marketing Abbott, GSK, J&J, JJ, M&A, MA, Novartis, Pfizer, Wyeth, generics, industry, merger, year in review

This year saw two ‘mega mergers’ in the sector, the acquisition of Wyeth by Pfizer and the reverse takeover of …
Feature

Contract research news in brief

December 22, 2009 Research and Development AAIPharma, Benten BioServices, CRO, Covance, ICON, PharmaVigilant, Phase Forward, SynRG

Our round-up of developments in the contract research sector includes updates from ICON, SynRG, AAIPharma, Covance, Benten BioServices, Phase Forward …
News

Sanofi’s Plavix combination recommended for European approval

December 21, 2009 Research and Development, Sales and Marketing DuoPlavin, Plavix, Sanofi, cabazitaxel, eplivanserin, idrabiotaparinux

Sanofi-Aventis has received the backing of a key European regulatory committee for its cardiology treatment DuoPlavin, which combines its blockbuster …
News

Dr Michael Rosenblatt appointed chief medical officer Merck

December 21, 2009 Research and Development, Sales and Marketing Dr Michael Rosenblatt, Merck & Co, appointment, appointments, research and development, sales and marketing

Merck & Co. appoints Dr Michael Rosenblatt executive VP and chief medical officer. He will be the company’s primary voice …
Appointment
Merck & Co building

Merck buys Avecia to boost biomanufacturing

December 21, 2009 Manufacturing and Production, Research and Development Avecia Biologics, Cobra, Merck & Co, Recipharm

Merck & Co has bolstered its capabilities in biologics production with the acquisition of contract manufacturer Avecia Biologics. The deal …
News

Chiltern Announces Collaboration with Dr Nawab Qizilbash

December 18, 2009 Research and Development

Dr Nawab Qizilbash, MBChB BSc MRCP (UK) MSc Phil (Oxon) is the Director of OXON Epidemiology Ltd. He served as …
News
Press release
BI Centre_03 2

Boehringer’s ovarian cancer drug enters phase III

December 18, 2009 Research and Development, Sales and Marketing Boehringer, Cancer, ovarian

Boehringer Ingelheim has started a new phase III trial for its investigational cancer drug BIBF 1120. The LUME-Ovar-1 programme will …
News

UK supports stem cell research with online toolkit

December 18, 2009 Research and Development ReNeuron, regenerative medicine, stell cell

A new online resource has been launched to help stem cell researchers in the UK plan a regulatory route for …
News
ICON headquarters

ICON investments will come to fruition in 2010

December 16, 2009 Research and Development ICON, Manchester, translational

Irish contract research organisation ICON has provided additional details on its new translational medicine unit in Manchester, UK, first announced …
News

GSK signs needle-free vaccine alliance

December 16, 2009 Research and Development, Sales and Marketing GlaxoSmithKline, Intercell, patch, vaccines

GlaxoSmithKline has signed a deal with Intercell to see whether any of its vaccines could be made available in patch …
News
Nestle HQ image

The future is personalised

December 15, 2009 Research and Development, Sales and Marketing diagnostic, industry, nestle, personalised, pricewaterhousecoopers

A new report says the market for personalised medicine products is set to grow strongly over the next few years, …
News

Kendle appoints Christopher Bergen chief administrative officer and Simon Higginbotham chief marketing officer

December 15, 2009 Research and Development Kendle, appointment, research and development

Kendle has appointed Christopher Bergen to the newly-created role of chief administrative officer and executive vice president.Bergen was previously chief …
Appointment
Chris-Brinsmead100

AstraZeneca’s Chris Brinsmead and ex-health minister Lord Darzi appointed ambassadors for UK lifescience

December 15, 2009 Research and Development, Sales and Marketing AstraZeneca, Darzi, UK, appointment, research and development, sales and marketing

AstraZeneca UK’s chairman Chris Brinsmead and former health minister Lord Ara Darzi are among six newly appointed private sector business …
Appointment

Vision for £500m biomedical research hub in UK unveiled

December 14, 2009 Research and Development Paul Nurse, UKCMRI, Wellcome

Construction of a new biomedical research institute designed to bring the UK to the forefront of fundamental research in a …
News
The Gateway to Local Adoption Series

Latest content

BMS’ Opdivo/Yervoy combination accepted by Scottish Medicines Consortium for colorectal cancer

February 5, 2026

AstronauTx appoints Adam Rosenberg as Chair of the Board

February 5, 2026

Astellas Pharma’s Vyloy accepted by Scottish Medicines Consortium for gastric cancer

February 4, 2026

Angelini Pharma appoints Sergio Marullo di Condojanni as CEO

February 4, 2026

QV Bioelectronics secures £4.5m in funding for brain cancer therapy development

February 3, 2026